Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jeroen Veltman is active.

Publication


Featured researches published by Jeroen Veltman.


Breast Cancer Research and Treatment | 2004

The role of MRI in invasive lobular carcinoma.

Carla Boetes; Jeroen Veltman; Lya van Die; Peter Bult; Theo Wobbes; Jelle O. Barentsz

AbstractPurpose. To determine the value of MR imaging in the detection and measurement of tumor size in patients with invasive lobular carcinoma (ILC) compared to mammography and ultrasound. Materials and methods. From 36 cases of ILC in 34 patients who were surgically treated, the pre-operative imaging measurements, being mammography, ultrasound and contrast enhanced MR, were retrospectively re-evaluated for tumor detection and size. Findings were compared with pathology. Two radiologists were used for evaluation of the mammograms, the other imaging modalities were only evaluated by one radiologist. The Pearsons correlation test was used to determine the correlation between histopathological and imaging measurements for each imaging modality. Results. For mammography, ultrasound and MRI the false negative scores were respectively 14%, 3% and 0%. The percentage for underestimated, correctly estimated and overestimated measurements on imaging were 56%, 33% and 11% for radiologist 1 and 50%, 33% and 17% for radiologist 2 on mammography. For ultrasound and MRI these percentages were respectively 53%, 47%, 0% and 14%, 75%, 11%. The correlation coefficients for mammography were respectively r= 0.34 (p < 0.05) and r= 0.27 (p > 0.05) for both radiologists, for Ultrasound r= 0.24 (p > 0.05) and for MRI r= 0.81 (p < 0.01). Conclusion. Of the three imaging modalities contrast enhanced MR has the lowest false negative rate in detecting ILC and has the highest accuracy in measuring the size of the ILC. MR could play a key role in the pre-operative work-up for accurate tumor size determination.


European Radiology | 2008

Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions

Jeroen Veltman; Mark J. Stoutjesdijk; Ritse M. Mann; Henkjan J. Huisman; Jelle O. Barentsz; Johan G. Blickman; C. Boetes

The value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in characterizing breast lesions on magnetic resonance imaging (MRI) was evaluated. Sixty-eight malignant and 34 benign lesions were included. In the scanning protocol, high temporal resolution imaging was combined with high spatial resolution imaging. The high temporal resolution images were recorded every 4.1 s during initial enhancement (fast dynamic analysis). The high spatial resolution images were recorded at a temporal resolution of 86 s (slow dynamic analysis). In the fast dynamic evaluation pharmacokinetic parameters (Ktrans, Ve and kep) were evaluated. In the slow dynamic analysis, each lesion was scored according to the BI-RADS classification. Two readers evaluated all data prospectively. ROC and multivariate analysis were performed. The slow dynamic analysis resulted in an AUC of 0.85 and 0.83, respectively. The fast dynamic analysis resulted in an AUC of 0.83 in both readers. The combination of both the slow and fast dynamic analyses resulted in a significant improvement of diagnostic performance with an AUC of 0.93 and 0.90 (P = 0.02). The increased diagnostic performance found when combining both methods demonstrates the additional value of our method in further improving the diagnostic performance of breast MRI.


Radiology | 2015

MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50-75 Years with Extremely Dense Breasts: The DENSE Trial Study Design

Marleen J. Emaus; Marije F. Bakker; Petra H.M. Peeters; Claudette E. Loo; Ritse M. Mann; Mathijn de Jong; Robertus H.C. Bisschops; Jeroen Veltman; Katya M. Duvivier; Marc Lobbes; Ruud M. Pijnappel; Nico Karssemeijer; Harry J. de Koning; Maurice A. A. J. van den Bosch; Evelyn M. Monninkhof; Willem P. Th. M. Mali; Wouter B. Veldhuis; Carla H. van Gils

Women with extremely dense breasts have an increased risk of breast cancer and lower mammographic tumor detectability. Nevertheless, in most countries, these women are currently screened with mammography only. Magnetic resonance (MR) imaging has the potential to improve breast cancer detection at an early stage because of its higher sensitivity. However, MR imaging is more expensive and is expected to be accompanied by an increase in the number of false-positive results and, possibly, an increase in overdiagnosis. To study the additional value of MR imaging, a randomized controlled trial (RCT) design is needed in which one group undergoes mammography and the other group undergoes mammography and MR imaging. With this design, it is possible to determine the proportion of interval cancers within each study arm. For this to be an effective screening strategy, the additional cancers detected at MR imaging screening must be accompanied by a subsequent reduction in interval cancers. The Dense Tissue and Early Breast Neoplasm Screening, or DENSE, trial is a multicenter RCT performed in the Dutch biennial population-based screening program (subject age range, 50-75 years). The study was approved by the Dutch Minister of Health, Welfare and Sport. In this study, mammographic density is measured by using a fully automated volumetric method. Participants with extremely dense breasts (American College of Radiology breast density category 4) and a negative result at mammography (Breast Imaging Recording and Data System category 1 or 2) are randomly assigned to undergo additional MR imaging (n = 7237) or to be treated according to current practice (n = 28 948). Participants provide written informed consent before the MR imaging examination, which consists of dynamic breast MR imaging with gadolinium-based contrast medium and is intended to be performed for three consecutive screening rounds. The primary outcome is the difference in the proportions of interval cancers between the study arms. Secondary outcomes are the number of MR imaging screening-detected cancers, proportions of false-positive results, diagnostic yield of MR imaging, tumor characteristics, quality of life, and cost effectiveness.


Investigative Radiology | 2005

Magnetic resonance-guided biopsies and localizations of the breast: initial experiences using an open breast coil and compatible intervention device.

Jeroen Veltman; Carla Boetes; Theo Wobbes; Johan G. Blickman; Jelle O. Barentsz

Objective:The objective of this study was to evaluate the performance of a new commercially available open breast coil and compatible intervention device (Machnet) for magnetic resonance image (MRI)-guided breast interventions. Materials and Methods:Breast lesions detected on MRI were evaluated using MRI-guided core biopsy (n = 20) and/or preoperative wire localization (n = 23) on histologic outcome and accuracy of localization. Time needed to perform a procedure and occurring problems were recorded. Results:Mean lesion size was <10 mm. Two of 20 lesions could not be biopsied because they were out of range for the device. Biopsies were conclusive in half of the cases; most lesions missed were <10 mm. The average accuracy for needle placement in the localization procedures was less than 2 mm (range, 0–5 mm). The average procedure time was 40 minutes for a biopsy procedure and 33 minutes for an MRI-guided localization. Conclusions:Preoperative MRI-guided localizations can be performed quickly and accurately. However, in MRI-guided core biopsies, especially in small lesions, the device does not guarantee conclusive histologic evaluation of the lesion targeted.


European Journal of Radiology | 2011

MRI-guided breast biopsy at 3T using a dedicated large core biopsy set: feasibility and initial results

Carla Meeuwis; Ritse M. Mann; Roel Mus; Axel Winkel; Carla Boetes; Jelle O. Barentsz; Jeroen Veltman

OBJECTIVE The increasing importance of breast MRI in the diagnostic processes concerning breast cancer yield often lesions that are visible on MRI only. To assess the nature of these lesions, pathologic analysis is necessary. Therefore, MR-guided biopsy should be available. Breast MRI at 3T has shown advantage over 1.5T. Unfortunately, current equipment for MR-guided biopsy is better suited for intervention at 1.5T due to the danger of heating titanium co-axial sleeves and large susceptibility artifacts. We evaluated a dedicated 3T breast biopsy set that uses plastic coaxial needles to overcome these problems. MATERIALS AND METHODS We performed MRI-guided breast biopsy in 23 women with 24 MRI-only visible breast lesions at 3T. Biopsy procedures were performed with plastic coaxial needles in a closed bore 3T clinical MR system on a dedicated phased array breast coil with a commercially available add-on stereotactic biopsy device. RESULTS Width of the needle artifact was 2mm in all 24 cases. Biopsy procedure was completed between 35 and 67 min. The procedure was judged moderately easy in 12 and normal in 10 cases. One procedure was judged difficult and there was one technical failure. CONCLUSION MRI-guided breast biopsy at 3T is a fast and accurate procedure. The plastic coaxial needles reduce the susceptibility artifact largely and do not increase the difficulty of the procedure. The diagnostic yield is at least equal to the diagnostic yield of the same procedure at 1.5T. Therefore, this technique can be safely used for lesions only visible at 3T MRI.


Journal of Magnetic Resonance Imaging | 2011

Comparison of enhancement characteristics between invasive lobular carcinoma and invasive ductal carcinoma.

Ritse M. Mann; Jeroen Veltman; Henkjan J. Huisman; C. Boetes

To compare enhancement characteristics between invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) on contrast enhanced MRI of the breast and to observe the magnitude of eventual differences as these may impair the diagnostic value of breast MRI in ILC.


European Journal of Radiology | 2010

The additional value of three time point color coding in dynamic contrast-enhanced MRI of the breast for inexperienced and experienced readers

Jeroen Veltman; Ritse M. Mann; F.J.A. Meijer; R. A. M. Heesakkers; M. Heufke; Johan G. Blickman; C. Boetes

PURPOSE To evaluate the additional value of the color coding of dynamic data using the 3TP method in the evaluation of contrast-enhanced breast MRI for readers with different levels of experience. MATERIALS AND METHODS A total of 52 lesions were included in this study, 25 malignant and 27 benign. All lesions were evaluated by four readers on two different workstations for the evaluation of dynamic breast MRI; one displaying the subtracted images and relative enhancement versus time curves and one displaying the subtracted images together with the 3TP color coding projected onto pre-contrast T1 images. Readers with different levels of experience were used. The diagnostic performance of both workstations was evaluated using ROC curve analyses. Interobserver variations were evaluated using kappa statistics. RESULTS All lesions were detected by all four readers on both workstations. The diagnostic performance found in the inexperienced readers improved significantly when using the 3TP evaluations (p=0.04 and p=0.03). No significant difference was found for the more experienced readers (p=0.94 and p=0.54). The level of agreement between the readers improved significantly when using the 3TP evaluation method (p=0.01). CONCLUSION Even though the 3TP color coding did not improve the diagnostic performance of the more experienced readers, this study clearly shows its value for inexperienced readers. The use of 3TP color coding is therefore recommended for inexperienced readers.


Radiology | 2006

Prostate Cancer Localization with Dynamic Contrast-enhanced MR Imaging and Proton MR Spectroscopic Imaging

Jurgen J. Fütterer; Stijn W.T.P.J. Heijmink; Tom W. J. Scheenen; Jeroen Veltman; Henkjan J. Huisman; Pieter E. Vos; Christina A. Hulsbergen-van de Kaa; J. Alfred Witjes; Paul F. M. Krabbe; Arend Heerschap; Jelle O. Barentsz


Ejso | 2008

The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma of the breast

Ritse M. Mann; Jeroen Veltman; Jelle O. Barentsz; Theo Wobbes; Johan G. Blickman; C. Boetes


Clinical Imaging | 2006

Mammographic detection and staging of invasive lobular carcinoma.

Jeroen Veltman; C. Boetes; L. van Die; Peter Bult; Johan G. Blickman; Jelle O. Barentsz

Collaboration


Dive into the Jeroen Veltman's collaboration.

Top Co-Authors

Avatar

Jelle O. Barentsz

Radboud University Nijmegen

View shared research outputs
Top Co-Authors

Avatar

Ritse M. Mann

Radboud University Nijmegen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

C. Boetes

Radboud University Nijmegen Medical Centre

View shared research outputs
Top Co-Authors

Avatar

Henkjan J. Huisman

Radboud University Nijmegen

View shared research outputs
Top Co-Authors

Avatar

Nico Karssemeijer

Radboud University Nijmegen Medical Centre

View shared research outputs
Top Co-Authors

Avatar

Theo Wobbes

Radboud University Nijmegen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge